QIAGEN NV (QGEN)
34.58
+0.97
(+2.89%)
USD |
NYSE |
Apr 30, 16:00
34.58
0.00 (0.00%)
Pre-Market: 20:00
QIAGEN EPS Diluted (Quarterly) : 0.519 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InflaRx NV | -0.2115 |
| CDT Equity, Inc. | -231.44 |
| LENZ Therapeutics, Inc. | -1.155 |
| Liminatus Pharma, Inc. | -0.3018 |
| Oruka Therapeutics, Inc. | -0.5436 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 107.83M |
| Revenue (Quarterly) | 540.42M |
| Total Expenses (Quarterly) | 432.59M |
| Enterprise Value | 7.837B |
| Gross Profit Margin (Quarterly) | 59.77% |
| Profit Margin (Quarterly) | 19.95% |
| Earnings Yield | 5.91% |
| Operating Earnings Yield | 7.25% |
| Normalized Earnings Yield | 6.435 |